{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:04:04Z","timestamp":1784552644196,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cmi.2026.02.023","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:27:09Z","timestamp":1772209629000},"page":"1286-1292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Language, trust, and the polio endgame: words matter in vaccine communication"],"prefix":"10.1016","volume":"32","author":[{"given":"Sotirios","family":"Tsiodras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hanscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pikka","family":"Jokelainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Felix","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Barac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effrossyni","family":"Gkrania-Klotsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mora-Rillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casandra","family":"Bulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Pa\u00f1o-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Xavier","family":"Lescure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.02.023_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15585\/mmwr.mm7319a4","article-title":"Progress toward poliomyelitis eradication \u2013 worldwide, January 2022\u2013December 2023","volume":"73","author":"Geiger","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.15585\/mmwr.mm7215a3","article-title":"Update on wild poliovirus type 1 outbreak \u2013 southeastern Africa, 2021\u20132022","volume":"72","author":"Davlantes","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.15585\/mmwr.mm7325a2","article-title":"Persistent transmission of circulating vaccine-derived poliovirus \u2013 Somalia, January 2017\u2013March 2024","volume":"73","author":"Mendes","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmi.2024.10.003","article-title":"Poliomyelitis in Gaza","volume":"31","author":"Gupta","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.02.023_bib5","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJM199112193252504","article-title":"Strategies for the global eradication of poliomyelitis by the year 2000","volume":"325","author":"Wright","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.02.023_bib6","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/jvi.69.8.4972-4978.1995","article-title":"Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine","volume":"69","author":"Bouchard","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.cmi.2026.02.023_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005483","article-title":"Cold-Adapted Viral Attenuation (CAVA): highly temperature sensitive polioviruses as novel vaccine strains for a next generation inactivated poliovirus vaccine","volume":"12","author":"Sanders","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.02.023_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.15585\/mmwr.mm7214a3","article-title":"Update on vaccine-derived poliovirus outbreaks \u2013 worldwide, January 2021\u2013December 2022","volume":"72","author":"Bigouette","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15585\/mmwr.mm7341a1","article-title":"Update on vaccine-derived poliovirus outbreaks \u2013 worldwide, January 2023\u2013June 2024","volume":"73","author":"Namageyo-Funa","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(23)02844-1","article-title":"Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in the Gambia: a phase 3, double-blind, randomised controlled trial","volume":"403","author":"Ochoge","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.02.023_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1473-3099(23)00631-X","article-title":"Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in the Gambia: an observational cohort study","volume":"24","author":"Bashorun","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.023_bib12","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.023_bib13","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(21)00453-9","volume":"22","author":"Cooper","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.023_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101508","article-title":"Global epidemiology of vaccine-derived poliovirus 2016\u20132021: a descriptive analysis and retrospective case-control study","volume":"50","author":"Lai","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cmi.2026.02.023_bib16","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1016\/j.vaccine.2022.08.008","article-title":"Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020","volume":"41","author":"Macklin","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(23)00688-6","article-title":"Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study","volume":"24","author":"Cooper","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.023_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.11604\/pamj.supp.2023.45.2.38033","article-title":"Deployment of novel oral polio vaccine type 2 under emergency use listing in Nigeria: the rollout experience","volume":"45","author":"Asekun","year":"2023","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.cmi.2026.02.023_bib19","doi-asserted-by":"crossref","first-page":"A122","DOI":"10.1016\/j.vaccine.2022.02.050","article-title":"Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): novel oral polio vaccine type 2 (nOPV2) experience","volume":"41","author":"Macklin","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciaf151","article-title":"Clinical and epidemiological investigation of vaccine-derived poliovirus type 2 outbreak in Pakistan during 2019\u20132021","volume":"82","author":"Mehmood","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.023_bib21","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the expanded programme on immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.02.023_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.15585\/mmwr.mm7049a1","article-title":"Update on vaccine-derived poliovirus outbreaks \u2013 worldwide, January 2020\u2013June 2021","volume":"70","author":"Alleman","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-publhealth-090419-102240","article-title":"Vaccine hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health","volume":"42","author":"Dub\u00e9","year":"2021","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.cmi.2026.02.023_bib24","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1186\/s12889-023-16047-2","article-title":"Say it right: measuring the impact of different communication strategies on the decision to get vaccinated","volume":"23","author":"Avelino-Silva","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cmi.2026.02.023_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/21645515.2018.1522468","article-title":"Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness","volume":"15","author":"Larson","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2026.02.023_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(25)01037-2","article-title":"Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.02.023_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2237374","article-title":"Recent trends in vaccine coverage and confidence: a cause for concern","volume":"19","author":"Eagan","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2026.02.023_bib28","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/j.vaccine.2023.08.044","article-title":"The impact of the COVID-19 pandemic on parental vaccine hesitancy: a cross-sectional survey","volume":"41","author":"Grills","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127834","article-title":"Hesitancy towards routine childhood vaccinations before and after the COVID-19 pandemic in Arkansas","volume":"66","author":"Cima","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib30","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.15585\/mmwr.mm7243a1","article-title":"Routine vaccination coverage \u2013 worldwide, 2022","volume":"72","author":"Kaur","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.15585\/mmwr.mm7343a4","article-title":"Routine vaccination coverage \u2013 worldwide, 2023","volume":"73","author":"Jones","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.15585\/mmwr.mm7144a2","article-title":"Routine vaccination coverage \u2013 worldwide, 2021","volume":"71","author":"Rachlin","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2026.02.023_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.07.040","article-title":"Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines","volume":"42","author":"Santibanez","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126631","article-title":"Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates","volume":"45","author":"Moghtaderi","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1473-3099(22)00366-8","article-title":"Addressing vaccine inequities among Ukrainian refugees","volume":"22","author":"Hill","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.023_bib36","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1073\/pnas.1323502111","article-title":"Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010","volume":"111","author":"Drexler","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2026.02.023_bib37","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1186\/s12889-025-23903-w","article-title":"Breaking barriers: a qualitative study on polio vaccine hesitancy in Herat Province, Afghanistan","volume":"25","author":"Sillab","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cmi.2026.02.023_bib38","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/vaccines11071206","article-title":"Exploring knowledge and perceptions of polio disease and its immunization in polio high-risk areas of Pakistan","volume":"11","author":"Habib","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cmi.2026.02.023_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4269\/ajtmh.23-0154","article-title":"Vaccine refusal: a major, underestimated obstacle for the poliomyelitis eradication initiative","volume":"109","author":"Seytre","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2026.02.023_bib40","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1016\/j.vaccine.2017.09.075","article-title":"Understanding vaccine hesitancy in polio eradication in northern Nigeria","volume":"35","author":"Taylor","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-090804","article-title":"Socioeconomic determinants potentially underlying differential global SARS-CoV-2 testing capacity: an ecological study","volume":"15","author":"Moreira-Soto","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2026.02.023_bib42","doi-asserted-by":"crossref","first-page":"A128","DOI":"10.1016\/j.vaccine.2022.05.020","article-title":"Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria","volume":"41","author":"Lorenzetti","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.02.023_bib43","series-title":"Communication for development guidance for cVDPV2 outbreak response including the use of novel OPV2 (nOPV2)","year":"2021"},{"key":"10.1016\/j.cmi.2026.02.023_bib44","series-title":"Recommendations for reporting on poliovirus outbreaks: a media guide for journalists writing about circulating vaccine-derived polioviruses (cVDPVs) and polio eradication","year":"2022"},{"key":"10.1016\/j.cmi.2026.02.023_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.20344\/amp.19953","article-title":"Combating vaccine hesitancy requires knowledge of misfortunes and controversies","volume":"36","author":"Pinto Junior","year":"2023","journal-title":"Acta Med Port"},{"key":"10.1016\/j.cmi.2026.02.023_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2190\/37T3-TDH8-GLRT-WU5W","article-title":"Polio, politics, publicity, and duplicity: ethical aspects in the development of the Salk vaccine","volume":"8","author":"Brandt","year":"1978","journal-title":"Int J Health Serv"},{"key":"10.1016\/j.cmi.2026.02.023_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2024.101544","article-title":"Inaccurate communication in health sciences: the case of \u2018partial artemisinin resistance\u2019 for the treatment of malaria","volume":"62","author":"Hanscheid","year":"2024","journal-title":"New Microbe New Infect"},{"key":"10.1016\/j.cmi.2026.02.023_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2024.101552","article-title":"How a GPT-aided survey reveals a medical student\u2019s misunderstanding of the term \u2018artemisinin resistance\u2019","volume":"63","author":"Pereira","year":"2025","journal-title":"New Microbe New Infect"},{"key":"10.1016\/j.cmi.2026.02.023_bib49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijid.2020.05.058","article-title":"Pathways to COVID-19 'community protection'","volume":"96","author":"Marais","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.cmi.2026.02.023_bib50","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-065483","article-title":"Strategies for improving vaccine communication and uptake","volume":"153","author":"O\u2019Leary","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.cmi.2026.02.023_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2025.105361","article-title":"Policy recommendations for healthcare authorities, organizations and professionals on vaccine hesitancy in Europe: from evidence to practice","volume":"158","author":"Correia","year":"2025","journal-title":"Health Policy"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:23:59Z","timestamp":1784550239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1198743X26000819"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.02.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Language, trust, and the polio endgame: words matter in vaccine communication","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}